(Q34718423)

4 August 2017

title

Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control (English)

1 reference

4 August 2017

Bin S Teh

1

1 reference

4 August 2017

Wei-Yuan Mai

2

1 reference

4 August 2017

Walter H Grant

3

1 reference

4 August 2017

J Kam Chiu

4

1 reference

4 August 2017

Hsin H Lu

5

1 reference

4 August 2017

L Steven Carpenter

6

1 reference

4 August 2017

Shiao Y Woo

7

1 reference

4 August 2017

E Brian Butler

8

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

20

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

437-451

1 reference

Does the "peacock" have anything to do with radiotherapy?

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

The field-matching problem as it applies to the peacock three dimensional conformal system for intensity modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Potential clinical efficacy of intensity-modulated conformal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

The effect of dose on local control of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

External beam radiotherapy dose response of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Efficacy of selective alpha-1 blocker therapy in the treatment of acute urinary symptoms during radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

The linear-quadratic formula and progress in fractionated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Treatment of secretory pituitary adenoma with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Optic nerve sheath meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Orbital meningiomas: surgery, radiotherapy, or hormones?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Re-irradiation for locally recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Intensity-modulated radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Clinical realization of 3D conformal intensity modulated radiotherapy: Regarding bortfeld et al., IJROBP 30:899–908; 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

In response to Drs. Goitein and Niemierko

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

The hazard of accelerated tumor clonogen repopulation during radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Twice-a-day radiation therapy for cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Role of radiation therapy for 'juvenile' angiofibroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Irradiation of meningiomas of the intracranial anterior visual pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120002143

21 January 2018

Identifiers

DOI

10.1081/CNV-120002143

1 reference

4 August 2017

1 reference